Hospital-Acquired Infection Diagnostics Market Trends, Size, Share, Demand, Application, Technologic

The development of technologically advanced products is positively impacting the hospital-acquired infection (HAI) diagnostics domain. Advancements in technology have revolutionized the HAI diagnostics domain by enabling the development of products that offer reliable results in less time. For instance, in 2017, Roche Diagnostics launched the cobas Liat PCR system with four assays with the ability to conduct a real-time PCR nucleic acid test for Clostridium difficile detection in 20 minutes. Browse Detailed Report Summary with In-depth TOC on : https://www.psmarketresearch.com/market-analysis/hospital-acquired-infection-diagnostics-market Further, the rising awareness about various infections has resulted in the increasing requirement for disease screening in emerging economies. Infections in healthcare settings spread due to deficient waste management system, and unsafe use of blood products and medical devices. The World Health Organization revealed that the proportion of unsterilized syringe and injection reuse is between 1.5 and 69.4 percent in transitional and emerging economies. Therefore, the HAI diagnostics domain is headed toward a prosperous future owing to technological advancements. Browse Detailed Report Summary with In-depth TOC on : https://www.psmarketresearch.com/market-analysis/hospital-acquired-infection-diagnostics-market